 due to CLI
optional stenting vs
RCTs (627 patients
(OR, 0.83; 95% CI, 0.39-1.77).
patients included and
routine stenting with
with IC or CLI and
Technical success was signiﬁcantly
imprecision)
nitinol stents
SFA disease)234
higher in the stenting group (96% vs
64%; OR, 0.31; 95% CI, 0.09-0.92).
The 12-month binary restenosis rate
was signiﬁcantly lower in the primary
stenting group (OR, 3.02; 95% CI,
1.3-6.71)7
Comparison of various
Network meta-analysis Technical success was highest with
C (indirect comparisons,
stents
of 16 RCTs (2532
covered stents. Vascular restenosis
CLI patients included,
patients with IC or
was lowest with paclitaxel DES and
imprecision)
CLI and FP arterial
with paclitaxel-coated balloons.
disease)235
Major amputations were rare in all
treatment and control groups
(pooled amputation rate of 0.7
events/100 person-years)
Vein grafts vs PTFE
1 RCT in 43 claudicant Complication rates were 5% for PTFE B (imprecision, small
patients (86 limbs)230 and 12% for saphenous vein graft, no number of events)
operative deaths or perioperative
amputations for either procedure.
Primary, assisted primary, and
secondary patency rates at
72 months: 68%, 68%, and 77% for
PTFE and 76%, 83%, and 85% for
saphenous vein graft
Endovascular vs surgical
reconstruction

Four RCTs and six
observational studies
reporting on 2817
patients with FP
arterial disease233

CI, Conﬁdence interval; CLI, critical limb ischemia; DES, drug-eluting stent; OR, odds